Hims & Hers raised its full-year 2026 revenue guidance to a range of $2.8 billion to $3 billion, representing growth of 19% to 28% from 2025 levels, and updated adjusted EBITDA guidance to a range of $275 million to $350 million.
highest efficacy of any peptide class studied to date
Urva S, OFarrell L, Du Y, Loh MT, Hemmingway A, Qu H, et al
Unafraid of a headache or a belly rumble, advocates maintain that glutathione helps combat age-related changes by stimulating the repair of damaged tissue and promoting the production of new, healthy cells
Protein shakes work especially well when eating solid food seems hard
Tirzepatides Tirzepatides are medications that mimic two natural hormones (GLP-1 and GIP) to help regulate blood sugar and appetite